What is Anamorelin?

Anamorelin (Anamorelin) is an oral non-hormonal selective hunger receptor mimetic. It belongs to a special class of drugs and is mainly used to treat weight loss caused by muscle wasting diseases. The drug's mechanism of action involves simulating hunger receptors in the brain, thereby stimulating appetite and increasing patients' interest in food, helping them increase food intake and improve overall nutritional status.

What makes Anamorelin special is its non-hormonal nature, unlike traditional hormonal therapies. Its main effect is through interaction with the ghrelin receptor (GHrelin receptor). GHrelin is a gastric endocrine hormone and is considered to be the main hormone that stimulates appetite. By mimicking the GHrelin receptor, anamulin can trigger food cravings, thereby increasing the patient's food intake.

Anamulin is commonly used to treat weight loss due to muscle-wasting diseases such as cancer. Cancer patients may experience weight loss and loss of appetite due to the tumor itself or as a side effect of cancer treatment, such as chemotherapy or radiation. The use of anamorelin can help improve the overall condition and quality of life of these patients.

Before taking anamorelin, patients usually need a detailed evaluation by their doctor to determine the most appropriate dosage and treatment regimen. Anamorelin dosage is usually based on the patient's weight, overall health, and severity of the disease to ensure optimal treatment.

Anamorelin is not yet available in the country, so patients cannot purchase it domestically and need to purchase it through overseas channels. There are only original Anamorelin drugs available abroad, mainly from Japan, and the price is around more than 6,000 yuan.